Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endothelin-1-Mediated Drug Resistance in EGFR-Mutant Non-Small Cell Lung Carcinoma.
Pulido I, Ollosi S, Aparisi S, Becker JH, Aliena-Valero A, Benet M, Rodríguez ML, López A, Tamayo-Torres E, Chuliá-Peris L, García-Cañaveras JC, Soucheray M, Dalheim AV, Salom JB, Qiu W, Kaja S, Fernández-Coronado JA, Alandes S, Alcácer J, Al-Shahrour F, Borgia JA, Juan O, Nishimura MI, Lahoz A, Carretero J, Shimamura T. Pulido I, et al. Among authors: chulia peris l. Cancer Res. 2020 Oct 1;80(19):4224-4232. doi: 10.1158/0008-5472.CAN-20-0141. Epub 2020 Aug 3. Cancer Res. 2020. PMID: 32747363 Free PMC article.
Aberrant TIMP-1 production in tumor-associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma.
Duch P, Díaz-Valdivia N, Gabasa M, Ikemori R, Arshakyan M, Fernández-Nogueira P, Llorente A, Teixido C, Ramírez J, Pereda J, Chuliá-Peris L, Galbis JM, Hilberg F, Reguart N, Radisky DC, Alcaraz J. Duch P, et al. Among authors: chulia peris l. Cancer Sci. 2024 May;115(5):1505-1519. doi: 10.1111/cas.16141. Epub 2024 Mar 12. Cancer Sci. 2024. PMID: 38476010 Free PMC article.